What is the current Gases for Pharmaceutical and Biotechnology market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Gases for Pharmaceutical and Biotechnology market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the major challenges faced by the Gases for Pharmaceutical and Biotechnology market?

Stringent regulatory requirements and high production costs are major challenges.

Which regions are the leaders in the Gases for Pharmaceutical and Biotechnology market?

North America and Europe are the leading regions in the market.

What are the future opportunities in the Gases for Pharmaceutical and Biotechnology market?

Emerging economies and innovative technologies offer future growth opportunities.

How does technology impact the Gases for Pharmaceutical and Biotechnology market?

Advances in technology improve production efficiency and reduce costs.

What is the current regulatory landscape of the Gases for Pharmaceutical and Biotechnology market?

Regulations focus on safety, quality, and environmental sustainability.

What is the future outlook of the Gases for Pharmaceutical and Biotechnology market?

The market is expected to experience steady growth due to increasing demand.

Gases for Pharmaceutical and Biotechnology Industry Size, Share & Growth Forecast 2033

Gases for Pharmaceutical and Biotechnology by Application (Laboratory, Pharmaceutical and Biotechnology Companies, Others), by Types (Carbon Dioxide, Nitrogen, Oxygen, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 19.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 19.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gases for Pharmaceutical and Biotechnology Market Overview

The Gases for Pharmaceutical and Biotechnology market is a vital sector that plays a crucial role in the development and manufacturing of pharmaceutical and biotechnology products. As the demand for these products continues to rise, the Gases for Pharmaceutical and Biotechnology market size is expected to reach $1.4 billion by 2026, with a growth outlook that is poised to drive the industry's expansion. The market forecast suggests a Compound Annual Growth Rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as increasing demand for pharmaceuticals, advancements in technology, and stringent regulations. The scope of the market encompasses various types of gases, including oxygen, nitrogen, and carbon dioxide, which are used in various applications such as pharmaceutical manufacturing, biotechnology research, and medical devices.

Loading chart…

The key forces shaping the Gases for Pharmaceutical and Biotechnology industry include technology shifts, such as the adoption of cryogenic storage and gas delivery systems, regulations, such as those related to gas safety and environmental sustainability, and consumer behavior, such as the increasing demand for high-purity gases. The largest region in the market is North America, while the fastest-growing region is Asia Pacific, driven by the rapid expansion of the pharmaceutical and biotechnology sectors in countries such as China and India. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, opportunities, and challenges to drive business growth and success.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	18.34 billion
Growth rate	CAGR of 19.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Air Liquide; Linde; Air Products; Taiyo Nippon Sanso; Matheson; Messer Group; SOL Group; Coregas; INOX Air Products; HangYang; Shenzhen Gaofa Gas
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gases for Pharmaceutical and Biotechnology market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the industry's landscape.

Growth Drivers2 items

Increasing demand for pharmaceuticals and biotechnology products, particularly in the vaccine and gene therapy segments, is driving the need for high-purity gases, thus fueling the Gases for Pharmaceutical and Biotechnology market size.

Advancements in gas supply technologies, such as cylinder gas and liquid gas supply systems, are enhancing the efficiency and reliability of gas delivery, supporting the growth forecast of the Gases for Pharmaceutical and Biotechnology market.

Restraints2 items

Stringent regulations and standards for gas quality, purity, and safety, such as those set by the US FDA and EU GMP, can limit the entry of new players and increase the operational costs for existing manufacturers in the Gases for Pharmaceutical and Biotechnology market.

High initial investment requirements for establishing a gas manufacturing and distribution infrastructure can deter companies from entering the Gases for Pharmaceutical and Biotechnology market, thus affecting the overall Gases for Pharmaceutical and Biotechnology market size.

Opportunities2 items

Emerging economies, such as Asia-Pacific and Latin America, offer significant growth opportunities for the Gases for Pharmaceutical and Biotechnology market due to their increasing demand for pharmaceuticals and biotechnology products, driven by growing populations and improving healthcare infrastructure.

The growing trend of personalized medicine and regenerative medicine is expected to drive the demand for high-purity gases, creating new opportunities for players in the Gases for Pharmaceutical and Biotechnology market to expand their product offerings and services.

Challenges2 items

Fluctuations in raw material prices, such as helium and oxygen, can impact the profitability of gas manufacturers and suppliers in the Gases for Pharmaceutical and Biotechnology market, affecting the overall growth forecast.

Ensuring the safety and quality of gas supplies, particularly in the context of cyrogenic and high-pressure applications, is a significant challenge for companies operating in the Gases for Pharmaceutical and Biotechnology market, requiring continuous investment in technology and training.

Market Segmentation

Loading chart…

The Application segment in the Gases for Pharmaceutical and Biotechnology market refers to the various uses of gases in pharmaceutical and biotechnology applications. This includes laboratory research, manufacturing of pharmaceuticals and biopharmaceuticals, and quality control. The application segment is a crucial part of the Gases for Pharmaceutical and Biotechnology segmentation, as it helps to identify the specific needs of different industries and tailor gas solutions accordingly. The pharmaceutical industry, for instance, requires high-purity gases for various applications, including chromatography and fermentation.

The Types segment in the Gases for Pharmaceutical and Biotechnology market encompasses various subtypes of gases, including oxygen, nitrogen, carbon dioxide, and helium. Each subtype has its own unique characteristics and applications, contributing to the overall market size. For example, oxygen is used in cell therapy and tissue engineering, while nitrogen is used in lyophilization and freeze-drying. Understanding the different types of gases and their applications is essential for market taxonomy and analyzing the Gases for Pharmaceutical and Biotechnology market.

Gases for Pharmaceutical and Biotechnology Segmentation Breakdown9 items

Application

Laboratory

Pharmaceutical and Biotechnology Companies

Others

Types

Carbon Dioxide

Nitrogen

Oxygen

Others

Regional Insights

Loading chart…

The Gases for Pharmaceutical and Biotechnology market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing investments in the pharmaceutical and biotechnology sectors, favorable policies, and a growing demand for high-quality healthcare products.

In North America, key drivers include adoption of advanced technologies, mature infrastructure, and a well-established ecosystem. Europe is driven by stringent regulations, high demand for pharmaceutical products, and significant investments in research and development. Asia Pacific is expected to drive the regional forecast with demographic factors, expanding healthcare infrastructure, and growing investments in the biotechnology sector.

Latin America and Middle East & Africa are expected to contribute smaller shares to the global market, with key drivers including growing demand for pharmaceutical products, improving infrastructure, and increasing adoption of advanced technologies. Overall, the Gases for Pharmaceutical and Biotechnology market is expected to experience significant growth, driven by factors such as ecosystem maturity, policies, and investments.

Competitive Landscape

The Gases for Pharmaceutical and Biotechnology market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Gases for Pharmaceutical and Biotechnology competitive landscape is characterized by high competition, with companies focusing on differentiation through product quality, service reliability, and channel strength.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their market position.

Air Liquide: regional expansion

Linde: vertical integration

Air Products: premium pricing

Taiyo Nippon Sanso: OEM tie-ups

Matheson: innovation pipeline

Messer Group: local manufacturing

Key Gases for Pharmaceutical and Biotechnology Companies11 items

Air Liquide

Linde

Air Products

Taiyo Nippon Sanso

Matheson

Messer Group

SOL Group

Coregas

INOX Air Products

HangYang

Shenzhen Gaofa Gas

Market Ecosystem

The Gases for Pharmaceutical and Biotechnology ecosystem spans upstream, midstream, and downstream activities, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and delivery of gases used in pharmaceutical and biotechnology applications. The ecosystem's boundaries are defined by the interactions among these participants, influencing how value flows and is captured.

Raw material suppliers — provide gas sourcing

OEMs/manufacturers — produce gas-related equipment

Technology providers — develop gas processing technologies

System integrators/EPCs — design and install gas systems

Distributors/channel partners — supply gases to end users

Regulators/standards bodies — set industry standards and regulations

End users/buyers — pharmaceutical and biotechnology companies

In the Gases for Pharmaceutical and Biotechnology ecosystem, value flows through the interactions among participants, with control points influencing adoption, such as regulatory approvals and industry standards. Dependency risks, including input constraints and approval timelines, can impact the ecosystem's functioning. Switching costs and partnerships also play a role, as companies may face challenges in changing suppliers or integrating new technologies. Furthermore, the ecosystem's characteristics may differ by region, with varying regulatory requirements and market demands. Understanding the ecosystem through a value chain analysis is essential to identifying these dynamics and navigating the complex interactions within the Gases for Pharmaceutical and Biotechnology ecosystem.

Recent Industry Insights

The Gases for Pharmaceutical and Biotechnology industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed, such as collaborations between gas suppliers and pharmaceutical companies to enhance production efficiency. Additionally, there have been key mergers and acquisitions, including the acquisition of smaller gas providers by larger companies to expand their market presence. Furthermore, innovative product and technology launches have been observed, with a focus on improving gas purity and delivery systems.

Regulatory changes have also impacted the industry, with updated guidelines for gas usage in pharmaceutical manufacturing. A shift in consumer trends has been observed, with a growing emphasis on sustainability and environmental responsibility. Funding rounds and expansions have been announced by several companies, aiming to increase their production capacity and develop new technologies. These developments are expected to drive growth in the Gases for Pharmaceutical and Biotechnology industry, shaping its future trajectory.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Gases for Pharmaceutical and Biotechnology market outlook. The market exhibits moderate attractiveness, driven by increasing demand for pharmaceuticals and biotechnology products. The competitive intensity is high, with key players competing for market share. The long-term outlook is positive, with the market expected to grow steadily over the forecast period.

The innovation landscape is characterized by ongoing research and development in gas applications for pharmaceutical and biotechnology manufacturing. The demand-supply balance is relatively stable, with suppliers adapting to changing demand patterns. However, key risk factors include fluctuations in raw material prices and regulatory changes. Overall, the market offers opportunities for growth, but companies must navigate these challenges to remain competitive.

11 items

1. Executive Summary

2. Gases for Pharmaceutical and Biotechnology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gases for Pharmaceutical and Biotechnology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Gases for Pharmaceutical and Biotechnology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory

6.1.2. Pharmaceutical and Biotechnology Companies

6.1.3. Others

6.2. Global Gases for Pharmaceutical and Biotechnology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Carbon Dioxide

6.2.2. Nitrogen

6.2.3. Oxygen

6.2.4. Others

6.3. Global Gases for Pharmaceutical and Biotechnology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Gases for Pharmaceutical and Biotechnology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gases for Pharmaceutical and Biotechnology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gases for Pharmaceutical and Biotechnology Market Competition by Key Manufacturers

8.1. Global Gases for Pharmaceutical and Biotechnology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Gases for Pharmaceutical and Biotechnology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Air Liquide

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Linde

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Air Products

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Taiyo Nippon Sanso

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Matheson

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Messer Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SOL Group

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Coregas

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. INOX Air Products

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. HangYang

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Shenzhen Gaofa Gas

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gases for Pharmaceutical and Biotechnology Market

Figure 4: Global Gases for Pharmaceutical and Biotechnology Market: Drivers

Figure 5: Global Gases for Pharmaceutical and Biotechnology Market: Challenges

Figure 6: Global Gases for Pharmaceutical and Biotechnology Market: Trends

Figure 7: Global Gases for Pharmaceutical and Biotechnology Market: Opportunity

Figure 8: Global Gases for Pharmaceutical and Biotechnology Market: Restraint

Figure 9: Global Gases for Pharmaceutical and Biotechnology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Gases for Pharmaceutical and Biotechnology Market Value (USD Million) By Region

Figure 15: Global Gases for Pharmaceutical and Biotechnology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Gases for Pharmaceutical and Biotechnology Market Value (USD Million) By Region

Figure 23: Global Gases for Pharmaceutical and Biotechnology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Gases for Pharmaceutical and Biotechnology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gases for Pharmaceutical and Biotechnology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gases for Pharmaceutical and Biotechnology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Gases for Pharmaceutical and Biotechnology Market Value (USD Million) By Region

Table 10: Global Gases for Pharmaceutical and Biotechnology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Gases for Pharmaceutical and Biotechnology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Gases for Pharmaceutical and Biotechnology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Gases for Pharmaceutical and Biotechnology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Air Liquide Basic Information And Sales Area

Table 31: Air Liquide. Products Portfolio

Table 32: Linde Basic Information And Sales Area

Table 33: Linde. Products Portfolio

Table 34: Air Products Basic Information And Sales Area

Table 35: Air Products. Products Portfolio

Table 36: Taiyo Nippon Sanso Basic Information And Sales Area

Table 37: Taiyo Nippon Sanso. Products Portfolio

Table 38: Matheson Basic Information And Sales Area

Table 39: Matheson. Products Portfolio

Table 40: Messer Group Basic Information And Sales Area

Table 41: Messer Group. Products Portfolio

Table 42: SOL Group Basic Information And Sales Area

Table 43: SOL Group. Products Portfolio

Table 44: Coregas Basic Information And Sales Area

Table 45: Coregas. Products Portfolio

Table 46: INOX Air Products Basic Information And Sales Area

Table 47: INOX Air Products. Products Portfolio

Table 48: HangYang Basic Information And Sales Area

Table 49: HangYang. Products Portfolio

Table 50: Shenzhen Gaofa Gas Basic Information And Sales Area

Table 51: Shenzhen Gaofa Gas. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Gases for Pharmaceutical and Biotechnology Market Value (USD Million) By Region

Table 57: Global Gases for Pharmaceutical and Biotechnology Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Gases for Pharmaceutical and Biotechnology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	18.34 billion
Growth rate	CAGR of 19.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Air Liquide; Linde; Air Products; Taiyo Nippon Sanso; Matheson; Messer Group; SOL Group; Coregas; INOX Air Products; HangYang; Shenzhen Gaofa Gas
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Gases for Pharmaceutical and Biotechnology Segmentation Breakdown9 items

Application

Laboratory

Pharmaceutical and Biotechnology Companies

Others

Types

Carbon Dioxide

Nitrogen

Oxygen

Others

Regional Insights

Loading chart…

Competitive Landscape

Air Liquide: regional expansion

Linde: vertical integration

Air Products: premium pricing

Taiyo Nippon Sanso: OEM tie-ups

Matheson: innovation pipeline

Messer Group: local manufacturing

Key Gases for Pharmaceutical and Biotechnology Companies11 items

Air Liquide

Linde

Air Products

Taiyo Nippon Sanso

Matheson

Messer Group

SOL Group

Coregas

INOX Air Products

HangYang

Shenzhen Gaofa Gas

Market Ecosystem

Raw material suppliers — provide gas sourcing

OEMs/manufacturers — produce gas-related equipment

Technology providers — develop gas processing technologies

System integrators/EPCs — design and install gas systems

Distributors/channel partners — supply gases to end users

Regulators/standards bodies — set industry standards and regulations

End users/buyers — pharmaceutical and biotechnology companies

Recent Industry Insights

Analyst Overview

Table of Contents